CS
CELL

Credit Suisse’s PhenomeX Inc. Common Stock CELL Stock Holding History

Credit Suisse’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-27,000
Closed -$1.21M – 4603
2021
Q2 		$1.21M Buy
27,000
+18,300
+210% +$848K ﹤0.01% 3239
2021
Q1 		$437K Buy
+8,700
New +$593K ﹤0.01% 3852

Other funds holding CELL

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
NIMC
Nierenberg Investment Management Company Camas, Washington $201M AUM 36.3% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Credit Suisse's CELL Position: Q1 2023 in Review

Credit Suisse sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2023, closing a stake of 2 shares — an estimated $5 sold.

Credit Suisse first reported a position in CELL in Q2 2021 and held it in 4 quarters. The position peaked at $550K in Q2 2021. 102 funds tracked by Wall St. Rank hold CELL as of Q1 2023.

  • Credit Suisse reported no remaining PhenomeX Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Credit Suisse sold 2 PhenomeX Inc. Common Stock shares in Q1 2023, an estimated $5.
  • Credit Suisse first reported a position in PhenomeX Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • Credit Suisse's PhenomeX Inc. Common Stock position peaked at $550K in Q2 2021.
  • 102 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.